<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01670838</url>
  </required_header>
  <id_info>
    <org_study_id>Kuopio UH</org_study_id>
    <nct_id>NCT01670838</nct_id>
  </id_info>
  <brief_title>Cardiopulmonary Complication in Aneurysmal Subarachnoid Haemorrhage Patients</brief_title>
  <acronym>SAHHEART</acronym>
  <official_title>Cardiopulmonary Complication in Aneurysmal Subarachnoid Haemorrhage Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective cohort study investigating cardiac function and cardiac biomarkers in
      patients with acute Aneurysmal Subarachnoid Haemorrhage (aSAH). The aims of the study are to
      document the incidence of myocardial dysfunction,to find the predictive factors of myocardial
      dysfunction, describe heart rate variability and to assess the impact of all cardiac problems
      on morbidity and mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laboratory markers daily: Routine laboratory test (blood gases, haemoglobin, thrombocytes,
      leukocytes, INR, bilirubin, creatinine, c-reactive protein, CK, CK-MB, Tnt, BNP, sodium,
      potassium, magnesium) are taken at 8 a.m. Study laboratory tests (sensitive ischemia markers,
      remodelling marker MMP-9 and CgA as surrogate marker for increased sympathetic activity) are
      taken four times during study period at the same time as cardiac ECHOes and Holtering. Gene
      sample is taken once on day one.

      Primary outcome measurement is to document the incidence of myocardial dysfunction and the
      predictive factors during the hospital stay and at three months.

      Secondary outcome is to assess the impact of cardiac problems on morbidity and mortality
      during first three months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">August 2017</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of cardiac failure and the impact of cardiac problems on morbidity</measure>
    <time_frame>6 months</time_frame>
    <description>The aims of the study are:
to document the incidence of myocardial dysfunction
to find the predictive factors of myocardial dysfunction as determined by the severity aneurysmal bleeding (Hunt and Hess-grading, Glasgow coma score, Fisher scale) and demographic factors
to find predictive factors for myocardial dysfunction as determined by laboratory findings, electrocardiography, and echocardiography
to describe heart rate variability
to assess the impact of all cardiac problems on morbidity</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">198</enrollment>
  <condition>Aneurysmal Subarachnoid Heamorrhage</condition>
  <condition>Nontraumatic Subarachnoid Haemorrhage</condition>
  <arm_group>
    <arm_group_label>subarachnoid haemorrhage</arm_group_label>
    <description>nontraumatic subarachnoid haemorrhage</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      MICRORNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study material consists of 200 consecutive aSAH-patients treated in Kuopio University
        Hospital and Turku University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with nontraumatic subarachnoid haemorrhage

          -  Age &gt; 18 years

          -  Aneurysmal bleeding

        Exclusion Criteria:

          -  No consent

          -  Age &lt; 18 years

          -  Anticipated brain death &lt; 24 hours

          -  Otherwise moribund patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stepani Bendel, PhD, MD</last_name>
    <role>Study Director</role>
    <affiliation>Senior consultant, intensivist</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maarit LÃ¥ng, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senior consultant, intensivist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>PL 1777</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inselspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2012</study_first_submitted>
  <study_first_submitted_qc>August 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2012</study_first_posted>
  <last_update_submitted>March 14, 2018</last_update_submitted>
  <last_update_submitted_qc>March 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Maarit Lang</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>subarachnoid haemorrhage</keyword>
  <keyword>cardiopulmonary complications</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

